ArticleAmerican heart journal plus : cardiology research and practice2024

OCEANIC-AF and the inferior efficacy of asundexian compared to apixaban in patients at high risk with atrial fibrillation: Have we come to the end of the road for factor XIa inhibitors?

Keith C Ferdinand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.